| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |